NCT05990465 2026-02-23LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell MalignanciesMedical College of WisconsinPhase 1 Recruiting12 enrolled
NCT06948786 2025-11-26Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL TrialUniversity of WashingtonPhase 2 Recruiting22 enrolled